MSF Access

@msfaccess.org

NEW EVIDENCE: Analogue #insulin is associated with improved management & regulation of blood sugar levels for people with #diabetes. Data from two new studies in low- and middle-income countries, including those affected by humanitarian crises, below. 👇

Today, MSF called for the inclusion of analogue insulin pens to Kenya’s Social Health Authority (SHA) benefits package. Doing so would align with Kenyan and WHO guidelines, and ensure that more people have access to more efficacious and person-preferred treatments.

The Ebola disease outbreak in eastern Democratic Republic of the Congo (DRC) and Uganda revealed a critical diagnostic blind spot in existing Ebola surveillance and testing systems. DRC authorities have expanded laboratory testing capacity, but timely access remains a challenge.

A drug exists that is nearly 100% effective at preventing HIV and only needs to be taken twice a year. It's called lenacapavir. But Gilead, the company that controls it, isn't making enough available for the world. We know Gilead can make lenacapavir more accessible.

Bild

This Ebola disease outbreak once again exposes persistent failures to ensure that accessible medical tools for diseases disproportionately affecting low- and middle-income countries are prioritised, funded, and produced as part of R&D. It has to change now. msfaccess.org/principles-e...

❓ What’s an access ____________ gap? 👉 Bridging these gaps and protecting people’s basic right to access healthcare is not easy, but it is possible, and we’re working on it. 👇 Read our latest newsletter to find out more! msfaccess.org/newsletter/w...

What’s an access ____ gap?

These gaps manifest themselves in many ways, from conflicts that delay lifesaving vaccines from being delivered to people, fuelling deadly, vaccine-preventable disease outbreaks, to failures to attach...

msfaccess.org

⏰ “This outbreak can still be brought under control, but the window for action is narrowing.” One month after the Ebola disease outbreak was declared in DRC, major gaps in surveillance, diagnosis, contact tracing and community engagement persist.

DRC: MSF warns dangerous gaps persist in Ebola disease response | MSF

Despite the recent scale-up in the Ebola disease response in Democratic Republic of Congo (DRC), major gaps in surveillance, diagnosis, contact tracing and community engagement persist.

msf.me

In San Pedro Sula, Honduras, we're improving access to sexual and reproductive health services for adolescents.  🎥 Diana Dáila, our medical activity manager in Honduras, tells us how her team provides this care.

Cancer is becoming one of the most serious health challenges in Papua New Guinea. Patients often come in late for care, and there is limited capacity for diagnosis and treatment. Our new cancer initiative in Morobe province is addressing gaps in care:

Papua New Guinea: Strengthening cancer care in Morobe | MSF

A new MSF project in Papua New Guinea is strengthening cancer care, including palliative care, at ANGAU Memorial Provincial hospital, in collaboration with local authorities.

msf.me

With no validated treatments or vaccines yet, and limited diagnostics for Bundibugyo virus disease, R&D and funding must embed transparent and enforceable conditions from the outset to guarantee timely, sustainable access to affordable medical tools for the most affected communities.

Ebola disease caused by the Bundibugyo virus.
What is different this time?
- No validated therapeutics or vaccines
- Limited diagnostic tools
Bundibugyo virus is different than other virus causing Ebola disease.Rapid initiatives, resources and actions are being mobilised at national, regional and international levels.

Now is the time to ensure that conditions that guarantee access are embedded in R&D and funding initiatives.Principles to ensure access for the most affected people and countries:
- Affected people, communities and countries must be at the front and centre of R&D and access decisions. 
- Ensure enforceable access conditions across R&D funding governance
- Transparency and accountability should guide publicly funded response and coordination

👋 Meet Nombuso Ntshalintshali, our laboratory manager at Sitsandziwe clinic in Eswatini! Her lab uses a ‘test and treat’ approach, giving fast, accurate results for sexually transmitted infections so that patients can get targeted medications that reduce the risk of antibiotic resistance.

Bild

🥁 We’re continuing our drumbeat call of analogue insulin pens for all at #WHA79. It’s time for countries & @who.int to end the double standard in diabetes care and include analogue insulin pens and glucose monitoring devices in all diabetes guidelines. msfaccess.org/follow-polit...

Follow-up to the political declaration of the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases – WHA79/12.1

MSF statement on noncommunicable diseases at the 79th World Health Assembly

msfaccess.org

This week, we're right here at the World Health Assembly #WHA79, calling for countries to make sure global health policies for the coming years ensure everyone, everywhere has access to affordable medical products.

📢 This World Health Assembly #WHA79, we’re calling for countries, donors, and other global health stakeholders to urgently dismantle the barriers blocking access to lifesaving vaccination in conflict-affected settings by:

Did you know that the Pandemic Agreement, signed one year ago, is still on hold because of an annex? Enter the PABS* annex! * Pathogen Access and Benefit Sharing

In South Kivu, Democratic Republic of Congo, a new challenge is disrupting healthcare. Funding withdrawals are making vital care inaccessible, particularly for pregnant women and newborns. Read our latest press release here ⬇️

Eastern DRC: Minova is on the brink of a healthcare crisis | MSF

Obstetric care has become inaccessible to women in South Kivu, Democratic Republic of Congo, as donor organisations have recently withdrawn from the area.

msf.org

From five ways to improve vaccine access to outrage over pharma failing to address the barriers stopping people from accessing HIV prevention medication, explore our call for disease prevention not to be a privilege in our latest MSF Access newsletter: msfaccess.org/newsletter/f...

Five key pathways to improve vaccine access you should know about

This month, we talk about barriers in accessing medical tools needed for disease prevention and explore how we can go about bringing these barriers down. During World Immunisation Week (24-30 April), ...

msfaccess.org